Hims & Hers Health Inc. (HIMS) Q4 2025 (USD): Adj. EBITDA 66.3mln (exp. 61.8mln), Revenue 618mln (exp. 619mln), Q1 adj. EBITDA view 35-55mln (exp. 81.7mln), revenue view 600-625mln (exp 653mln).

Hims & Hers Health Inc.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

US President Trump on Truth says "If we don't make a deal, it will be a very bad day for Iran"

JPMorgan (JPM) sees FY Net Interest Income at about USD 104.5bln (prev. 103bln); maintains FY NII ex-CIB markets around USD 95bln

Hims & Hers Health Inc. (HIMS) Q4 2025 (USD): Adj. EBITDA 66.3mln (exp. 61.8mln), Revenue 618mln (exp. 619mln), Q1 adj. EBITDA view 35-55mln (exp. 81.7mln), revenue view 600-625mln (exp 653mln).

Diamondback Energy Inc. (FANG) Q4 2025 (USD) Adj. EPS 1.74 (exp. 2.00), Revenue 3.38bln (exp. 3.28bln)

US President Trump exploring new retirement savings plan and may address it in State of the union, Semafor reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

FY guidance

  • Adj. EBITDA 300-375mln (exp. 366.6mln).
  • Revenue 2.7-2.9bln (exp. 2.74bln).
Context

reported Q4 earnings that showed an adjusted EBITDA beat expectations, though revenues fell slightly short. However, the starkly lower guidance for Q1 suggests potential concerns about future growth momentum, likely prompting scrutiny of the company's operational challenges. This could lead to downward pressure on the stock as investors reassess expectations against the broader market context.

Related headlines

The whole workspace, free to try.

Try it free